MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.ccell.2021.01.001

Медицинская библиотека · Cancer cell · 2021

Acute Immune Signatures and Their Legacies in Severe Acute Respiratory Syndrome Coronavirus-2 Infected Cancer Patients.

Abdul-Jawad Sultan, Baù Luca, Alaguthurai Thanussuyah, Del Molino Del Barrio Irene, Laing Adam G, Hayday Thomas S, Monin Leticia, Muñoz-Ruiz Miguel, McDonald Louisa, Francos Quijorna Isaac, McKenzie Duncan, Davis Richard, Lorenc Anna, Chan Julie Nuo En, Ryan Sarah, Bugallo-Blanco Eva, Yorke Rozalyn, Kamdar Shraddha, Fish Matthew, Zlatareva Iva, Vantourout Pierre, Jennings Aislinn, Gee Sarah, Doores Katie, Bailey Katharine, Hazell Sophie, De Naurois Julien, Moss Charlotte, Russell Beth, Khan Aadil A, Rowley Mark, Benjamin Reuben, Enting Deborah, Alrifai Doraid, Wu Yin, Zhou You, Barber Paul, Ng Tony, Spicer James, Van Hemelrijck Mieke, Kumar Mayur, Vidler Jennifer, Lwin Yadanar, Fields Paul, Karagiannis Sophia N, Coolen Anthony C C, Rigg Anne, Papa Sophie, Hayday Adrian C, Patten Piers E M, Irshad Sheeba

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

Given the immune system's importance for cancer surveillance and treatment, we have investigated how it may be affected by SARS-CoV-2 infection of cancer patients. Across some heterogeneity in tumor type, stage, and treatment, virus-exposed solid cancer patients display a dominant impact of SARS-CoV-2, apparent from the resemblance of their immune signatures to those for COVID-19+ non-cancer patients. This is not the case for hematological malignancies, with virus-exposed patients collectively displaying heterogeneous humoral responses, an exhausted T cell phenotype and a high prevalence of prolonged virus shedding. Furthermore, while recovered solid cancer patients' immunophenotypes resemble those of non-virus-exposed cancer patients, recovered hematological cancer patients display distinct, lingering immunological legacies. Thus, while solid cancer patients, including those with advanced disease, seem no more at risk of SARS-CoV-2-associated immune dysregulation than the general population, hematological cancer patients show complex immunological consequences of SARS-CoV-2 exposure that might usefully inform their care.

Для цитирования: Abdul-Jawad Sultan, Baù Luca, Alaguthurai Thanussuyah, Del Molino Del Barrio Irene, Laing Adam G, Hayday Thomas S, Monin Leticia, Muñoz-Ruiz Miguel, McDonald Louisa, Francos Quijorna Isaac, McKenzie Duncan, Davis Richard, Lorenc Anna, Chan Julie Nuo En, Ryan Sarah, Bugallo-Blanco Eva, Yorke Rozalyn, Kamdar Shraddha, Fish Matthew, Zlatareva Iva, Vantourout Pierre, Jennings Aislinn, Gee Sarah, Doores Katie, Bailey Katharine, Hazell Sophie, De Naurois Julien, Moss Charlotte, Russell Beth, Khan Aadil A, Rowley Mark, Benjamin Reuben, Enting Deborah, Alrifai Doraid, Wu Yin, Zhou You, Barber Paul, Ng Tony, Spicer James, Van Hemelrijck Mieke, Kumar Mayur, Vidler Jennifer, Lwin Yadanar, Fields Paul, Karagiannis Sophia N, Coolen Anthony C C, Rigg Anne, Papa Sophie, Hayday Adrian C, Patten Piers E M, Irshad Sheeba. Acute Immune Signatures and Their Legacies in Severe Acute Respiratory Syndrome Coronavirus-2 Infected Cancer Patients.. Cancer cell. 2021. DOI: 10.1016/j.ccell.2021.01.001.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.